The federal government has made an astonishing admission.The National Cancer Institute, one of the federal government’s sponsored agencies has cited evidence of cancer cell death as a result of cannabinoids.
The federal government has made an astonishing admission.The National Cancer Institute, one of the fed’s sponsored agencies has just updated the FAQs on their websites to include recent studies illustrating cannabis’ ability to kill cancer cells.
Cannabinoids have the potential to inhibit tumor growth by causing cell death, impeding cell growth, and preventing the development of blood vessels required by tumors to grow. Laboratory and animal studies have revealed that cannabinoids may be able to kill cancer cells while protecting normal cells.
Cannabinoids can protect against inflammation of the colon and may have the ability to reduce the risk of colon cancer, and possibly in its treatment.
A laboratory study of delta -9-THC in hepatocellular carcinoma (liver cancer) cells illustrates it damaged or killed the cancer cells. Furthermore, the same study of delta-9-THC in models of liver cancer indicated that it had anti-tumor effects. Delta-9-THC has been revealed to trigger these effects by acting on molecules that may also be located in non-small cell lung cancer cells and breast cancer cells.
In addition a laboratory study on cannabidiol (CBD) in estrogen receptor positive and estrogen receptor negative breast cancer cells illustrated that it initiated cancer cell death while having minute effect on normal breast cells. Studies of metastatic breast cancer showed that cannabinoids may decrease the number, growth and spread of tumors.
CBD was also studied in tandem with chemotherapy. A laboratory study of cannabidiol in human glioma cells illustrated that when provided along with chemotherapy, CBD can make chemotherapy more effective and increase cancer cell death without damaging normal cells. Studies indicate that CBD along with delta-9-THC have the potential to make chemotherapy such as temozolomide more effective.
The NCI has categorized these studies as preclinical. They were all done using animals. In addition, the NCI has listed findings on additional benefits for less severe effects of cancer.
Cannabinoids have been studies for their anti-inflammatory effects that could play a major role in pain relief. THC along with other cannabinoids stimulate appetite and can increase food intake. The endocannabinoid system has been studied in the brain, spinal cord, and nerve endings throughout the body to understand their roles in pain relief.
National Cancer Institute